Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients.
Saved in:
| Title: | Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients. |
|---|---|
| Authors: | Razia, Deepika1,2 dr.deepikarazia@gmail.com, Chengcheng Hu3 hucc@arizona.edu, Cherrier, Lauren1 Lauren.Cherrier@dignityhealth.org, Nasar, Aasya1 aasya.nasar@commonspirit.org, Walia, Rajat1,2 rajat.walia@dignityhealth.org, Tokman, Sofya1,2 sofya.tokman@commonspirit.org |
| Source: | Transplant Immunology. Dec2022, Vol. 75, p1-7. 7p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
